GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (LTS:0Q4U) » Definitions » Market Cap

Novonesis (Novozymes) B (LTS:0Q4U) Market Cap : kr187,610 Mil (As of Apr. 03, 2025)


View and export this data going back to 2006. Start your Free Trial

What is Novonesis (Novozymes) B Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Novonesis (Novozymes) B's share price for the quarter that ended in Dec. 2024 was kr409.65. Novonesis (Novozymes) B's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 464 Mil. Therefore, Novonesis (Novozymes) B's market cap for the quarter that ended in Dec. 2024 was kr190,223 Mil.

Novonesis (Novozymes) B's quarterly market cap increased from Dec. 2023 (kr102,857 Mil) to Jun. 2024 (kr198,257 Mil) but then declined from Jun. 2024 (kr198,257 Mil) to Dec. 2024 (kr190,223 Mil).

Novonesis (Novozymes) B's annual market cap increased from Dec. 2022 (kr97,031 Mil) to Dec. 2023 (kr102,857 Mil) and increased from Dec. 2023 (kr102,857 Mil) to Dec. 2024 (kr190,223 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Novonesis (Novozymes) B's Enterprise Value for Today is kr198,899 Mil.


Novonesis (Novozymes) B Market Cap Historical Data

The historical data trend for Novonesis (Novozymes) B's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Market Cap Chart

Novonesis (Novozymes) B Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 98,252.57 149,969.77 97,030.93 102,856.88 190,223.44

Novonesis (Novozymes) B Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88,529.20 79,418.68 102,856.88 198,256.79 190,223.44

Competitive Comparison of Novonesis (Novozymes) B's Market Cap

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B's Market Cap Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Market Cap distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Market Cap falls into.


;
;

Novonesis (Novozymes) B Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Novonesis (Novozymes) B's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=kr409.65*464.356
=kr190,223

Novonesis (Novozymes) B's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=kr409.65*464.356
=kr190,223

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis (Novozymes) B  (LTS:0Q4U) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Novonesis (Novozymes) B Market Cap Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis (Novozymes) B Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines